Omeros Stock Discussion

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$  Phase 2
$Supernus Pharmaceuticals(SUPN.US)$  Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$  Phase 2a
$MorphoSys(MOR.US)$  Phase 2
$Nuvation Bio(NUVB.US)$  Phase 2
$ALX Oncology(ALXO.US)$  Phase 2
$BioXcel Therapeutics(BTAI.US)$  Phase 2
$Purple Biotech(PPBT.US)$  Phase 2
$Arcus Biosciences(RCUS.US)$  Phase 2
$Medicenna Therapeutics(MDNAF.US)$  Phase 2b
$Affimed NV(AFMD.US)$  Phase 2
$Barinthus Biotherapeutics(BRNS.US)$  Phase 2b...

$Omeros(OMER.US)$ uptrending nicely ! 💪🏼

$Omeros(OMER.US)$ Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
7 MINUTES AGO, 9:05 AM EDT

$Omeros(OMER.US)$ sry for your loss!

$Omeros(OMER.US)$ • The ARTEMIS-IGAN trial did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo
• Proteinuria reduction in the placebo group was substantially greater than reported in other IgA nephropathy clinical trials
• Webcast conference call planned for 8:30 a.m. ET today

$Omeros(OMER.US)$ GOOD TO SELL OFF AND TRAVEL NOW, NHAO NHAO 🤗😋🥰👌👍

$Omeros(OMER.US)$ LAST CHANCE SELL OFF AND DELETE 👹

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Next week big pharma companies such as $Biogen(BIIB.US)$ , $Sage Therapeutics(SAGE.US)$ , and $Ironwood Pharmaceuticals(IRWD.US)$ will release their quarterly earnings report.
BIGGEST MOVERS FROM THIS WEEK
$Hillstream BioPharma(HILS.US)$ shares continued to trade up this week after it announced initial results from a study...

$Omeros(OMER.US)$ Better Sell Off get your profit, before it will open (Lower Over -1+) then ( - 💰💰💰💰💰💰💰)